| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

As shown in table 2, both OS and CBR values were in line or higher than those reported in the treatment arm of the ASCENT ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

For more information about Syncromune, please visit www.syncromune.com.

Auron Therapeutics begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies: Newton, Massachusetts Monday, June 2, 2025, 16:00 Hrs [IST] Auron Thera ...

The findings suggest that "the heightened focus on alternative endpoints, now representing the most common primary endpoint, ...

The oral presentation at the 2025 ASCO Annual Meeting (Abstract 4003) was titled "Claudin18.2-specific CAR T cells (Satri-cel ...

A novel triple reuptake inhibitor is efficacious and ‘clinically meaningful’ for adult attention-deficit/hyperactivity ...

A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...

Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...

The mortar had ripped through the hall’s canvas roof and sprayed shrapnel in every direction. Compared to others, Turner was ...

J INTS BIO, a company specializing in the development of therapeutics for cancer and rare diseases, officially announced ...